Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes
RIO DE JANEIRO — The addition of daratumumab to lenalidomide maintenance therapy following autologous stem cell transplant (ASCT) significantly improves rates of achieving minimal residual disease (MRD) negativity and progression-free survival (PFS) among patients newly diagnosed with multiple myeloma (MM),…
English